Drugs / Tiropramide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01629212 | Dec 2011 → Feb 2013 | irritable bowel syndrome | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tiropramide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01629212 ↗ |
| Known as | Tiropramida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104688 ↗ |
| Modality | Small molecule | — CHEMBL2104688 ↗ |